What is the recent research on kidney tumours?
Best insight from top research papers
Recent research on kidney tumors has focused on various aspects of these malignancies. Studies have explored the role of microRNAs (miRNAs) in renal cell carcinoma (RCC), with more than 82 miRNAs identified as being involved in renal cancers . The use of exosomes as mediators of intercellular communication in the tumor microenvironment has also been investigated, with potential applications for the diagnosis and treatment of kidney cancer . Additionally, a retrospective analysis of patients who underwent surgical removal of clear cell carcinoma found morpho-functional changes in the kidneys depending on tumor size and the presence of systemic diseases . The incidence of new cases of renal cell carcinoma has been increasing, and the role of trans-arterial embolization (TAE) in the treatment of these tumors has been explored, although the evidence for its effectiveness is inconclusive . Furthermore, the new WHO classification of renal tumors has improved the understanding and accurate diagnosis of these neoplasms .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The recent research on kidney tumors discussed in the paper focuses on the histomorphological features of various renal tumors and the classification of these tumors based on the new WHO classification. | |
| The recent research on kidney tumors discussed in the paper focuses on the use of trans-arterial embolization (TAE) in both neoadjuvant and palliative treatment regimens. The paper highlights the effects of TAE on reducing blood loss, surgery duration, and tumor volume, as well as its potential to increase cancer-specific survival rates after radical intervention. However, the paper also mentions conflicting findings regarding the ability of TAE to improve overall survival and its effectiveness in certain cases such as inferior vena cava thrombosis. The paper suggests the need for further randomized studies to establish the indications and effects of TAE in patients with kidney tumors. | |
| The recent research analyzed the examination and treatment results of 30 patients who underwent surgical removal of clear cell carcinoma in the kidneys. It studied the effect of tumor size and the presence of systemic diseases on morpho-functional changes in the kidneys. | |
16 Citations | The recent research on kidney tumors focuses on the role of microRNAs (miRNAs) in renal cancer, including their involvement in progression, diagnosis, therapy targeting, and prognosis of renal cell carcinoma (RCC). |
24 Citations | The provided paper discusses the role of exosomes in the diagnosis and treatment of kidney cancer, but it does not provide specific information on recent research on kidney tumors. |
Related Questions
What is a survival rate of Kidney cancer?4 answersThe survival rate of kidney cancer varies depending on the region and stage of diagnosis. In Asian countries, the one-year survival rate is 71%, the five-year survival rate is 69.4%, and the 10-year survival rate is 62.3%. In England, the survival outcomes for kidney cancer remained relatively unchanged, with age-standardized mortality rates remaining stable over the study duration. In the United States, the overall 5-year survival rate for kidney cancer is 76%, with regional disease having a 66.7% survival rate and metastatic disease having an 11.7% survival rate. Additionally, specific genetic mutations have been associated with reduced survival in clear cell renal cell carcinoma, such as VHL, BAP1, SDHA, SDHD, and ARID1A.
What are the latest studies looking at epigenetics and cancer?5 answersRecent studies have focused on the role of epigenetic modifications in cancer progression and treatment. Epigenetic changes, such as histone modification, DNA methylation, and non-coding RNA, have been shown to play a critical role in the development of therapeutic resistance in cancer. Targeting these epigenetic modifications with specific drugs, such as DNA methyltransferase inhibitors and histone deacetylase inhibitors, has the potential to reverse drug resistance and restore sensitivity to standard therapies. Additionally, the interplay between epigenetics and cancer immunology has been explored, with the aim of developing therapeutics that combine both approaches. The concept of the epigenetic landscape, which describes potential cellular fates and regulatory processes, has been applied to understand cancer etiology and the plasticity of cancerous states. Advances in single-cell analysis and molecular assays have enriched our understanding of the diversity of phenotypic states defined by epigenetic control. Overall, these studies contribute to our understanding of how epigenetic modifications influence cancer progression and provide insights for the development of targeted therapies.
What is the current state of the art in CAR-T cell therapy for kidney cancer?4 answersCAR-T cell therapy is an emerging treatment modality for kidney cancer that shows promise in improving patient outcomes. The approval of nivolumab as a second-line monotherapy and the recent approval of novel combination therapies as first-line treatment have established the significance of immunotherapy in renal cell carcinoma (RCC). CAR-T cell therapy involves genetically engineering T cells to express chimeric antigen receptors (CARs) that target specific tumor antigens. While CAR-T cell therapy has shown promise in hematological malignancies, its application in solid tumors, including RCC, is still being investigated. Challenges in CAR-T cell therapy for RCC include the lack of specific molecular targets, depletion of CAR-T cells, a hostile tumor microenvironment, and on/off-tumor toxicities. Ongoing research aims to overcome these obstacles and improve the efficacy of CAR-T cell therapy for kidney cancer.
How can new diagnostic methods be developed to improve the early detection and diagnosis of kidney cancer?5 answersNew diagnostic methods can be developed to improve the early detection and diagnosis of kidney cancer through the integration of multi-modal ultrasound videos. This can be achieved by using a novel multi-modal ultrasound video fusion network that effectively performs multi-modal feature fusion and video classification for renal tumor diagnosis. Additionally, the use of deep learning models such as Convolutional Neural Networks (CNNs) and Artificial Neural Networks (ANNs) can aid in the early diagnosis of kidney cancer by detecting kidney images and analyzing blood samples dataset values. Furthermore, the development of a hybrid neural fuzzy inference system combining CNNs with machine learning techniques has shown promise in accurately detecting and segmenting kidney tumors. The use of artificial intelligence (AI) and radiomics has also allowed for the development of AI-based computer-aided diagnostic/prediction (CAD/CAP) systems, which can aid in the early diagnosis of kidney cancer and prediction of clinical outcomes.
What is the latest research on cancer therapy?5 answersRecent research on cancer therapy has focused on various approaches including cell membrane-camouflaged nanoparticles for targeted drug delivery and therapy. Another strategy involves the use of antibody-drug conjugates (ADCs) to selectively deliver potent cytotoxic agents to tumor cells, improving efficacy and reducing systemic adverse events. Advances have also been made in the development of safe and efficient cancer nanomedicines, such as stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemodynamic therapy, sonodynamic therapy, and ferroptosis-based therapy. Additionally, there has been a growing interest in cancer gene therapy, with a focus on materials science and nanotechnology, gene delivery, and drug delivery. Furthermore, non-protein target drugs, particularly RNA therapeutics, including oligonucleotide drugs and mRNA vaccines, have shown promise in cancer treatment. These advancements highlight the importance of targeted drug delivery, personalized therapies, and innovative treatment modalities in the field of cancer therapy.
What current research in carcinogenesis is available?5 answersCurrent research in carcinogenesis includes studies on the molecular and genetic alterations leading to hepatocellular carcinoma (HCC). Enzymes such as epoxide hydrolases are being investigated for their role in detoxification of carcinogenic compounds as well as signal transduction and inflammatory control. Field cancerization and molecularly targeted prevention are being explored in the context of oral cancer development. The molecular basis of carcinogenesis, including the role of various genes, is being studied with a focus on chemical carcinogenesis. Different models of carcinogenesis, such as the virus model, somatic mutation model, and reading-error model, are being reviewed, along with the electronic theory of cancer. These studies aim to improve our understanding of the mechanisms underlying cancer development and to identify potential targets for prevention and treatment.